Concepedia
Statistics
Publications
7
Citations
479
H-Index
Active since
1978
Affiliations
Pfizer (United States)(Current)
W.E. Upjohn Institute for Employment Research
Jeffrey L. Havens is an author at Pfizer (United States) specializing in pharmacology, natural sciences, and chemistry.
Top concepts
PharmacologyChemistryNatural SciencesBiochemistryOrganic ChemistryMedicineEngineeringMedicinal ChemistryCatalysisBiophysics
Publications per year
1978–2009
Allylic oxidation with 3,5-dimethylpyrazole. Chromium trioxide complex steroidal .DELTA.5-7-ketones
William G. Salmond, M. A. BARTA, Jeffrey L. Havens · The Journal of Organic Chemistry · 1978 · 278 citations
Heterocyclic, Biochemistry, Donut Icon +12
Early Amidation Approach to 3-[(4-Amido)pyrrol-2-yl]-2-indolinones
Jerad M. Manley, Monica Kalman, Brian G. Conway et al. · The Journal of Organic Chemistry · 2003 · 99 citations
Early Amidation Approach, Amide Side Chain, Knorr Pyrrole Synthesis +7
A stereoselective Wittig reagent and its application to the synthesis of 25-hydroxylated vitamin D metabolites
William G. Salmond, M. A. BARTA, Jeffrey L. Havens · The Journal of Organic Chemistry · 1978 · 33 citations
Stereoselective Wittig Reagent, Bioorganic Chemistry, Biochemistry +12
Factor analysis of infrared spectra for solid-state forms of delavirdine mesylate
Ronald W. Sarver, P. A. MEULMAN, Darlene K. Bowerman et al. · International Journal of Pharmaceutics · 1998 · 26 citations
Natural Sciences, Spectroscopy, Infrared Spectroscopy +7
A New Approach to the Furan Degradation Problem Involving Ozonolysis of the <i>trans</i>-Enedione and Its Use in a Cost-Effective Synthesis of Eplerenone
Bruce A. Pearlman, Amphlett G. Padilla, John T. Hach et al. · Organic Letters · 2006 · 20 citations
Engineering, Chemical Transformation, Dimethyl Sulfide +16
1–5 of 7